Dg. Bailey et al., GRAPEFRUIT JUICE FELODIPINE INTERACTION - MECHANISM, PREDICTABILITY, AND EFFECT OF NARINGIN, Clinical pharmacology and therapeutics, 53(6), 1993, pp. 637-642
Grapefruit juice produces a marked and variable increase in felodipine
bioavailability. The pharmacokinetics of felodipine and its single pr
imary oxidative metabolite, dehydrofelodipine, were studied after drug
administration with 200 ml water, grapefruit juice, or naringin in wa
ter at the same concentration as the juice in a randomized crossover t
rial of nine healthy men. With grapefruit juice, mean +/- SEM felodipi
ne area under the plasma concentration-time curve (AUC) and peak plasm
a concentration (C(max)) were 206% +/- 23% (range, 123% to 330%, p < 0
.01) and 170% +/- 24% (range, 127% to 310%, p < 0.02), respectively, c
ompared with water. Dehydrofelodipine/felodipine ratios for AUC (1.5 /- 0.2 versus 2.2 +/- 0.2, p < 0.001) and felodipine C(max) (1.5 +/- 0
.2 versus 2.2 +/- 0.2, p < 0.001) were reduced, consistent with inhibi
tion of presystemic felodipine metabolism. Intersubject changes in fel
odipine and dehydrofelodipine AUC supported inhibition of both primary
and secondary metabolic steps as a mechanism. The interaction could n
ot be predicted from baseline pharmacokinetics with water and did not
result in more consistent bioavailability among individuals. Naringin
solution produced much less of an interaction, showing that other fact
ors were important.